FDCDDQ
OTLK icon

Federation des caisses Desjardins du Quebec’s Outlook Therapeutics OTLK Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262 Hold
1,312
– – ﹤0.01% 2860
2025
Q4 		$2.07K Hold
1,312
– – ﹤0.01% 2593
2025
Q3 		$1.36K Hold
1,312
– – ﹤0.01% 2638
2025
Q2 		$2.1K Hold
1,312
– – ﹤0.01% 2402
2025
Q1 		$1.6K Buy
+1,312
New +$2.3K ﹤0.01% 2364

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's OTLK Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Outlook Therapeutics (OTLK) position steady in Q1 2026 at 1,312 shares worth $262. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Federation des caisses Desjardins du Quebec first reported a position in OTLK in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.1K in Q2 2025. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 1,312 shares of Outlook Therapeutics worth $262 as of Q1 2026.
  • Federation des caisses Desjardins du Quebec left its Outlook Therapeutics share count unchanged in Q1 2026.
  • Outlook Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2860 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Outlook Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Federation des caisses Desjardins du Quebec's Outlook Therapeutics position peaked at $2.1K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.